Cite
HARVARD Citation
Reiss, S. et al. (2022). Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study. Leukemia & lymphoma. 63 (3), pp. 627-632. [Online].